Healio: PCI not cost-effective in patients with CAD, heart failure vs. optimal medical therapy Please provide your email address to receive an email when new articles are posted on . PCI was not cost-effective vs.

Understanding the Context

optimal medical therapy alone in patients with CAD and HF. Intervention conferred ... PCI not cost-effective in patients with CAD, heart failure vs. optimal medical therapy Healio: PCI may benefit patients with unblocked arteries but vulnerable plaque vs.

Key Insights

medical therapy PCI may benefit patients with unblocked arteries but vulnerable plaque vs. medical therapy News Medical: Dual-antiplatelet therapy should remain the standard strategy for PCI even in the drug-eluting stent era Prasugrel monotherapy after percutaneous coronary intervention (PCI) with drug-eluting stents is not superior to dual-antiplatelet therapy (DAPT) for major bleeding but is non-inferior for ... Dual-antiplatelet therapy should remain the standard strategy for PCI even in the drug-eluting stent era News Medical: Trial examines differences in gastrointestinal effects of antiplatelet therapy after PCI Medscape: AUGUSTUS Backs Apixaban in 'Double Therapy' for Most Patients With AF After ACS or PCI AUGUSTUS Backs Apixaban in 'Double Therapy' for Most Patients With AF After ACS or PCI Medscape: CLARITY-TIMI 28: Clopidogrel as Adjunctive Reperfusion Therapy - Thrombolysis in Myocardial Infarction 28: PCI and Ambulance Substudies CLARITY-TIMI 28: Clopidogrel as Adjunctive Reperfusion Therapy - Thrombolysis in Myocardial Infarction 28: PCI and Ambulance Substudies